(Q42464525)

1 November 2017

title

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer (English)

1 reference

1 November 2017

1 reference

1 reference

Lutz Trojan

1

1 reference

1 November 2017

Daniel Thomas

2

1 reference

1 November 2017

Thomas Knoll

3

1 reference

1 November 2017

Rainer Grobholz

4

1 reference

1 November 2017

Peter Alken

5

1 reference

1 November 2017

Maurice Stephan Michel

6

1 reference

1 November 2017

language of work or name

1 reference

1 May 2004

1 reference

1 November 2017

1 reference

1 November 2017

volume

32

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

97-103

1 reference

Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

1 November 2017

cites work

1 reference

12 December 2020

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1 reference

12 December 2020

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

12 December 2020

Anticancer therapy with angiogenesis inhibitors.

1 reference

12 December 2020

1 reference

12 December 2020

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

12 December 2020

Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.

1 reference

12 December 2020

Angiogenic molecules and cancer metastasis.

1 reference

12 December 2020

Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma

1 reference

12 December 2020

Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.

1 reference

12 December 2020

Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1

1 reference

12 December 2020

Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines

1 reference

12 December 2020

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs

1 reference

12 December 2020

Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer

1 reference

12 December 2020

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate

1 reference

12 December 2020

Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates

1 reference

12 December 2020

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro

1 reference

12 December 2020

The role of angiogenesis in prostate and other urologic cancers: a review

1 reference

12 December 2020

Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue

1 reference

12 December 2020

Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas

1 reference

12 December 2020

10.1007/S00240-003-0383-5

Identifiers

DOI

1 reference

1 November 2017

1 reference